Holdings
First Trust Health Care AlphaDEX Fund
As of Jul 31, 2026, First Trust Health Care AlphaDEX Fund reported 73 positions worth US$1.05B. Largest: Regeneron Pharmaceuticals, Inc., Universal Health Services, Inc. and Solventum Corporation. What it bought and sold, with each filing.
Holdings
- Part of
- First Trust
- Positions
- 73
- Value as reported
- US$1.05B
- Holdings as of
- Jul 31, 2026
- Last filed
- Sep 22, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | 38,060 | US$29M | 2.8% | +13,569 | Jul 31, 2026 |
| Universal Health Services, Inc. NYSE:UHS | 160K | US$26.9M | 2.6% | +53,868 | Jul 31, 2026 |
| Solventum Corporation NYSE:SOLV | 308K | US$26.3M | 2.5% | +17,815 | Jul 31, 2026 |
| Boston Scientific Corporation NYSE:BSX | 556K | US$26M | 2.5% | +499K | Jul 31, 2026 |
| Zimmer Biomet Holdings, Inc. NYSE:ZBH | 276K | US$25.9M | 2.5% | +66,381 | Jul 31, 2026 |
| Guardant Health, Inc. NASDAQ:GH | 158K | US$25.6M | 2.4% | new | Jul 31, 2026 |
| DaVita Inc. NYSE:DVA | 107K | US$25.6M | 2.4% | −16,458 | Jul 31, 2026 |
| Pfizer, Inc. NYSE:PFE | 986K | US$24.6M | 2.4% | +446K | Jul 31, 2026 |
| Tenet Healthcare Corporation NYSE:THC | 94,714 | US$24.1M | 2.3% | +14,495 | Jul 31, 2026 |
| The Cigna Group NYSE:CI | 86,083 | US$24M | 2.3% | +15,145 | Jul 31, 2026 |
| Globus Medical, Inc. NYSE:GMED | 300K | US$23.7M | 2.3% | +80,730 | Jul 31, 2026 |
| Medline Inc. NASDAQ:MDLN | 602K | US$23.6M | 2.3% | +432K | Jul 31, 2026 |
| Natera, Inc. NASDAQ:NTRA | 87,424 | US$23.4M | 2.2% | +30,654 | Jul 31, 2026 |
| Corcept Therapeutics Incorporated NASDAQ:CORT | 204K | US$23.3M | 2.2% | new | Jul 31, 2026 |
| Centene Corporation NYSE:CNC | 370K | US$23M | 2.2% | new | Jul 31, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 96,954 | US$21.1M | 2.0% | new | Jul 31, 2026 |
| Encompass Health Corporation NYSE:EHC | 175K | US$19.5M | 1.9% | +18,797 | Jul 31, 2026 |
| Medtronic plc. NYSE:MDT | 227K | US$19.3M | 1.8% | +95,474 | Jul 31, 2026 |
| ResMed Inc. NYSE:RMD | 90,923 | US$19.2M | 1.8% | +40,346 | Jul 31, 2026 |
| Zoetis Inc. NYSE:ZTS | 247K | US$19.1M | 1.8% | +183K | Jul 31, 2026 |
| Qiagen N.V. NYSE:QGEN | 453K | US$18.8M | 1.8% | +75,098 | Jul 31, 2026 |
| Halozyme Therapeutics, Inc. NASDAQ:HALO | 226K | US$18.7M | 1.8% | +109K | Jul 31, 2026 |
| Incyte Corporation NASDAQ:INCY | 156K | US$18.7M | 1.8% | −44,741 | Jul 31, 2026 |
| Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR | 217K | US$18.4M | 1.8% | new | Jul 31, 2026 |
| Neurocrine Biosciences, Inc. NASDAQ:NBIX | 105K | US$17.5M | 1.7% | +47,681 | Jul 31, 2026 |
| Elevance Health, Inc. NYSE:ELV | 45,819 | US$17.2M | 1.6% | −18,818 | Jul 31, 2026 |
| Eli Lilly and Company NYSE:LLY | 14,775 | US$17M | 1.6% | +6,546 | Jul 31, 2026 |
| United Therapeutics Corporation NASDAQ:UTHR | 32,701 | US$16.9M | 1.6% | +7,172 | Jul 31, 2026 |
| Ascendis Pharma A/S NASDAQ:ASND | 66,435 | US$16.2M | 1.5% | new | Jul 31, 2026 |
| Bristol-Myers Squibb Company NYSE:BMY | 247K | US$16.1M | 1.5% | +59,915 | Jul 31, 2026 |
| Viatris Inc. NASDAQ:VTRS | 897K | US$15.7M | 1.5% | new | Jul 31, 2026 |
| Labcorp Holdings Inc. NYSE:LH | 50,851 | US$15.7M | 1.5% | +8,298 | Jul 31, 2026 |
| Quest Diagnostics Incorporated NYSE:DGX | 67,178 | US$15.7M | 1.5% | +9,246 | Jul 31, 2026 |
| Becton, Dickinson and Company NYSE:BDX | 94,088 | US$15.6M | 1.5% | −2,191 | Jul 31, 2026 |
| Medpace Holdings, Inc. NASDAQ:MEDP | 26,886 | US$15.5M | 1.5% | +11,123 | Jul 31, 2026 |
| STERIS plc (Ireland) NYSE:STE | 67,620 | US$15.4M | 1.5% | +16,277 | Jul 31, 2026 |
| GE HealthCare Technologies Inc. NASDAQ:GEHC | 222K | US$15.1M | 1.4% | +62,938 | Jul 31, 2026 |
| Gilead Sciences, Inc. NASDAQ:GILD | 113K | US$14.7M | 1.4% | +31,236 | Jul 31, 2026 |
| Doximity, Inc. NYSE:DOCS | 687K | US$14.4M | 1.4% | new | Jul 31, 2026 |
| Revolution Medicines, Inc. NASDAQ:RVMD | 76,029 | US$14.3M | 1.4% | new | Jul 31, 2026 |
| Exelixis, Inc. NASDAQ:EXEL | 262K | US$13.9M | 1.3% | −179K | Jul 31, 2026 |
| Biogen Inc. NASDAQ:BIIB | 65,899 | US$13.4M | 1.3% | −37,317 | Jul 31, 2026 |
| IQVIA Holdings, Inc. NYSE:IQV | 45,853 | US$10.8M | 1.0% | +1,471 | Jul 31, 2026 |
| Abbott Laboratories NYSE:ABT | 97,638 | US$10.3M | 0.98% | +23,916 | Jul 31, 2026 |
| Veeva Systems Inc. NYSE:VEEV | 49,923 | US$10.2M | 0.97% | +29,725 | Jul 31, 2026 |
| Thermo Fisher Scientific Inc NYSE:TMO | 17,671 | US$10.1M | 0.97% | +2,273 | Jul 31, 2026 |
| Chemed Corp NYSE:CHE | 19,021 | US$10.1M | 0.97% | −21,055 | Jul 31, 2026 |
| BridgeBio Pharma, Inc. NASDAQ:BBIO | 119K | US$9.53M | 0.91% | new | Jul 31, 2026 |
| Ionis Pharmaceuticals, Inc. NASDAQ:IONS | 180K | US$9.3M | 0.89% | −22,024 | Jul 31, 2026 |
| Agilent Technologies, Inc. NYSE:A | 66,697 | US$9.23M | 0.88% | +291 | Jul 31, 2026 |
| HCA Healthcare, Inc. NYSE:HCA | 22,725 | US$9.15M | 0.87% | −17,260 | Jul 31, 2026 |
| Henry Schein, Inc. NASDAQ:HSIC | 106K | US$9.1M | 0.87% | −47,973 | Jul 31, 2026 |
| Align Technology, Inc. NASDAQ:ALGN | 52,527 | US$8.89M | 0.85% | +8,375 | Jul 31, 2026 |
| Organon & Co. NYSE:OGN | 654K | US$8.87M | 0.85% | −1.87M | Jul 31, 2026 |
| AbbVie Inc. NYSE:ABBV | 35,205 | US$8.83M | 0.84% | +18,892 | Jul 31, 2026 |
| Vertex Pharmaceuticals Incorporated NASDAQ:VRTX | 17,835 | US$8.51M | 0.81% | +9,890 | Jul 31, 2026 |
| Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL | 16,500 | US$7.71M | 0.74% | new | Jul 31, 2026 |
| Tempus AI, Inc. NASDAQ:TEM | 153K | US$6.71M | 0.64% | new | Jul 31, 2026 |
| DexCom, Inc. NASDAQ:DXCM | 65,774 | US$5.49M | 0.52% | +9,278 | Jul 31, 2026 |
| Illumina, Inc. NASDAQ:ILMN | 25,195 | US$5.17M | 0.49% | −66,915 | Jul 31, 2026 |
| The Ensign Group, Inc. NASDAQ:ENSG | 27,632 | US$4.92M | 0.47% | new | Jul 31, 2026 |
| Bio-Rad Laboratories, Inc. NYSE:BIO | 15,085 | US$4.91M | 0.47% | −52,798 | Jul 31, 2026 |
| Amgen Inc. NASDAQ:AMGN | 12,232 | US$4.71M | 0.45% | −30,793 | Jul 31, 2026 |
| IDEXX Laboratories, Inc. NASDAQ:IDXX | 8,415 | US$4.7M | 0.45% | +2,100 | Jul 31, 2026 |
| BioMarin Pharmaceutical Inc. NASDAQ:BMRN | 77,415 | US$4.65M | 0.44% | −56,573 | Jul 31, 2026 |
| Envista Holdings Corporation NYSE:NVST | 168K | US$4.59M | 0.44% | +28,264 | Jul 31, 2026 |
| Stryker Corporation NYSE:SYK | 14,068 | US$4.58M | 0.44% | +3,270 | Jul 31, 2026 |
| Danaher Corporation NYSE:DHR | 23,256 | US$4.53M | 0.43% | +4,543 | Jul 31, 2026 |
| Merck & Company, Inc. NYSE:MRK | 34,473 | US$4.49M | 0.43% | −91,373 | Jul 31, 2026 |
| Revvity, Inc. NYSE:RVTY | 39,813 | US$4.48M | 0.43% | −89,778 | Jul 31, 2026 |
| Johnson & Johnson NYSE:JNJ | 17,444 | US$4.47M | 0.43% | −13,521 | Jul 31, 2026 |
| The Cooper Companies, Inc. NASDAQ:COO | 61,771 | US$4.47M | 0.43% | −97,019 | Jul 31, 2026 |
| West Pharmaceutical Services, Inc. NYSE:WST | 12,340 | US$4.21M | 0.40% | −1,815 | Jul 31, 2026 |